Eugene Osei-Bonsu

Senior Director - Neuroscience Marketing and Strategy Lead - Global Portfolio D Takeda

Pharma Launch Excellence Summit Main Conference Day 2: Thursday 3rd December

9:00 AM Panel Discussion: The Future of Drug Pricing in 2027 & Beyond: Learning How the Most Favoured Nation Policy will Influence the Next Wave of Launches from a Commercial Standpoint

With the onset of The Most Favoured Nation policy poised to reshape global pricing strategies, launch teams must prepare for a changing market access landscape. This session will explore the policy's implications for launch sequencing, pricing, and commercial strategy across Europe and beyond.

• Understanding the latest MFN policy developments and what they mean for launch excellence teams around the globe

• Mapping the timeline and anticipated implementation of MFN to understand how it will affect global launches in 2027 and beyond

• Adapting launch sequencing, pricing, and market access strategies to capitalise on opportunities created by MFN policies

Pharma Launch Excellence Summit Pre-Conference Focus Day: Launch Excellence in Rare Disease: Tuesday 1st December

10:40 AM Panel Discussion: Partnering with Patient Advocacy Groups in Drug Development to Accelerate Rare Disease Launch Success

Patient advocacy groups can play a pivotal role in the successful development and launch of rare disease therapies. Early collaboration with patient advocacy groups can be a critical determinant of launch success. How can launch excellence teams ensure patient perspectives are meaningfully embedded throughout the drug development lifecycle?

• Building strong relationships with patients, caregivers, patient advocacy groups and external experts to maximise the success of your rare disease therapy launch

• Leveraging patient advocacy group partnerships to gain critical insights, engage diverse patient populations and support market access efforts to ensure your therapy successfully reaches patients who need it most

• Discovering how successful rare disease launches benefited from strong collaboration with patient advocacy groups to apply lessons learned to your next launch

Check out the incredible speaker line-up to see who will be joining Eugene.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk